Related Experiment Videos

Replication inhibition and translesion synthesis on templates containing site-specifically placed

K M Comess1, J N Burstyn, J M Essigmann

  • 1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, 02139.

Biochemistry
|April 28, 1992
PubMed

Insights

This study investigated DNA damage from the anticancer drug cis-diamminedichloroplatinum(II) (cis-DDP). Certain cis-DDP adducts significantly inhibit DNA replication, with T4 DNA polymerase being most affected, making it useful for mapping platinum-DNA adducts.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Anticancer drugs like cis-diamminedichloroplatinum(II) (cis-DDP) induce DNA damage.
  • Understanding how DNA adducts affect replication is crucial for drug development and therapy.

Purpose of the Study:

  • To synthesize and characterize site-specifically platinum-damaged M13 genomes.
  • To evaluate the impact of various cis-DDP DNA adducts on in vitro DNA replication by different polymerases.

Main Methods:

  • Construction of M13 genomes with specific cis-DDP adducts.
  • In vitro DNA replication assays using various DNA polymerases.
  • Analysis of replication products via gel electrophoresis and restriction enzyme digestion.

Main Results:

  • cis-DDP adducts caused an average of 10% bypass during DNA replication.
  • The cis-[Pt(NH3)2[d(GpG)-N7(1),-N7(2)]] adduct was the most inhibitory.
  • Bacteriophage T4 DNA polymerase showed the least translesion synthesis (2%), making it suitable for adduct mapping.

Conclusions:

  • DNA polymerase choice significantly influences the ability to bypass cis-DDP adducts.
  • T4 DNA polymerase is recommended for detecting cis-DDP adducts in DNA.
  • Trans-DDP adducts showed minimal inhibition to polymerases and restriction enzymes.

Related Concept Videos